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We examined translational initiation of a bicistronic 0.8-kb mRNA of Borna disease virus (BDV) using a cDNA clone of the
mRNA. Upon transfection with the clone, COS-7 cells produced a 16-kDa protein (P9), in addition to the previously identified
products of BDV, 24- (P) and 14.5-kDa proteins. The 16-kDa product was detected by anti-P monoclonal antibody and was
shown to exist in BDV-infected cell lines as well as in infected animal brain cells. Transient expression analysis of mutated
cDNA clones encoding the BDV 0.8-kb mRNA revealed that the 16-kDa protein was initiated at the second AUG codon on the
same open reading frame of the P protein. The mutational analysis also demonstrated that the first AUG within the 0.8-kb
mRNA is not optimal, although the signal contains a better Kozak’s motif. These results demonstrated the presence of three
functional AUG codons in the smallest mRNA of BDV and also suggested that a leaky scanning mechanism is involved in
translational initiation at AUG codons downstream of the bicistronic mRNA of BDV. Furthermore, the 16-kDa protein was
located in the BDV-specific nuclear foci and was found to associate with the other viral proteins in BDV-infected cells,
demonstrating an important role of the novel identified BDV protein in viral replication. © 2000 Academic Press
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Borna disease virus (BDV) is the causative agent of a
nonpurulent form of meningoencephalitis observed pre-
dominantly in horses and sheep (Ludwig et al., 1988; Stitz
et al., 1993). Recent studies have indicated that BDV can
infect humans and may be related to human mental
disorders (Rott et al., 1985; Bode et al., 1995; Kishi et al.,
995; Iwata et al., 1998; Nakamura et al., 2000). Molecular
iological analyses have shown that BDV has a nonseg-
ented, negative-stranded RNA genome of 8.9 kb, which
s present in the nucleus of the infected cells (Briese et
l., 1994; Cubitt et al., 1994; Cubitt and de la Torre, 1994;
e la Torre, 1994; Schneemann et al., 1995). The BDV
ntigenome consists of at least six open reading frames
ORFs). ORF I encodes a nucleoprotein (N) of 38 or 40
Da (Lipkin et al., 1990; McClure et al., 1992; Pyper et al.,
993). ORF II encodes a phosphoprotein (P) of 24 kDa
Lipkin et al., 1990; Thiedemann et al., 1992; Thierer et al.,
1992; Kliche et al., 1996). ORF III encodes an 18-kDa
matrix protein (M) (Kliche et al., 1994). ORF IV encodes a
protein of 57 kDa that is glycosylated to give a glyco-
protein of 84 or 96 kDa (G) (Gonzalez-Dunia et al., 1997;
Schneider et al., 1997a). ORF V encodes a predicted
RNA-dependent RNA polymerase (L) of 170 to 180 kDa
(Briese et al., 1994; Cubitt et al., 1994; Walker et al., 2000).
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296BDV-specific transcripts have been identified from the
poly(A)1 RNA extracted from rats infected with BDV strain
e/80-1 (Briese et al., 1994; Schneemann et al., 1994).
The 1.2-kb mRNA, which encodes the N protein, initiates
at nucleotide (nt) 43 in the BDV genome and ends at nt
1192 (Fig. 1A). The 0.8-kb mRNA, which contains the P
ORF, initiates at nt 1175 (Fig. 1A). Both 7.1- and 2.8-kb
mRNAs initiate at nt 1885, and the 2.8-kb transcript ter-
minates at nt 4511 and contains the M and G ORFs, while
the 7.1-kb mRNA contains the M, G, and L ORFs (Fig. 1A).
In addition, the 7.1- and 2.8-kb mRNAs are posttranscrip-
tionally modified by RNA splicing to yield at least four
additional RNAs of 6.1, 6.0, 1.5, and 1.4 kb (Schneider et
al., 1994; Schneemann et al., 1995). Recently, a small ORF
, which overlaps the P ORF, was reported to encode a
ovel protein X with an unknown function (Wehner et al.,
997). Interestingly, the X protein was suggested to be
ranslated from a bicistronic 0.8-kb mRNA that also en-
odes the P protein, because no monocistronic mRNA
ncoding only either X or P proteins has yet been de-
ected in BDV-infected cell lines or animal brain cells.
It is well known that some viruses produce mRNAs
hat have a polycistronic coding capacity, although it is
nusual in eukaryotic cells (Shaw et al., 1982; Bellini et
l., 1985; Ernst and Shatkin, 1985; Dillon and Gupta, 1989;
enanayake et al., 1992; Spiropoulou and Nichol, 1993).
tudies of these virus mRNAs demonstrated that poly-
istronic translation could be critical for efficient utiliza-
ion of the viral genome and also for their replication
Alkhatib et al., 1988; Williams and Lamb, 1989; Belli and
Samuel, 1993; Fouillot et al., 1993; Chenik et al., 1995;
ls. Lane
297TRANSLATION INITIATION OF BICISTRONIC mRNA OF BDVGupta et al., 1996). Although BDV produces mRNAs that
have bicistronic coding capacity such as 0.8- and 2.8-kb
mRNAs, only a little is known about the translation of
these mRNAs (VandeWoude et al., 1990; Thierer et al.,
1992; Schneider et al., 1997b). Since the 0.8-kb mRNA is
a major transcript of BDV, the proteins that are translated
from the mRNA must play important roles in replication of
the virus. Therefore, we analyzed translational initiation
of a bicistronic mRNA of BDV that encodes both X and P
proteins. Here, we report a novel form of the phospho-
protein of BDV, P9, which is translated at the second
initiation codon on the P ORF. Our results demonstrated
that there are three functional AUG codons in the small-
est transcript of BDV and also suggested that a leaky
scanning mechanism is involved in the translational ini-
tiation at AUG codons downstream of the mRNA.
RESULTS
A 16-kDa protein is produced from a bicistronic
mRNA of BDV
To investigate translation of the BDV mRNA that en-
FIG. 1. Translation of a 0.8-kb bicistronic mRNA of BDV. (A) Genomic o
(B) Detection of translation products of X/P mRNA. The X/P cDNA ex
SDS–PAGE. Western blotting analysis was carried out with different a
COS-7 cells; lanes 2, 6, and 10, pcX/P-transfected COS-7 cells; lanes 3, 7
C6 cells. (C) Detection of 16-kDa product in BDV-infected gerbil brain cel
gerbil brain cells.codes both X and P ORFs, we constructed a eukaryotic
expression plasmid encompassing the entire 0.8-kb (X/P)mRNA, pcX/P. Following transfection of COS-7 cells with
pcX/P, the cells were harvested at 48 h and subjected to
Western blot analysis. BDV-specific proteins were then
detected with anti-BDV rat serum. As shown in Fig. 1B,
the serum clearly detected three major bands of 24, 16,
and 14.5 kDa in the transfected cells (Fig. 1B, lane 2). In
addition to these bands, approximately 20-, 30-, and
40-kDa bands were also found in BDV-infected rat glial
tumor (C6) cells (Fig. 1B, lane 4). This observation was
consistent with previous studies indicating that the BDV
major proteins of 40 (N), 24 (P), and 14.5 kDa (X) were
expressed in both BDV-infected cultured cells and rat
brain cells (Schadler et al., 1985; Haas et al., 1986;
VandeWoude et al., 1990; Thiedemann et al., 1992;
Thierer et al., 1992; Wehner et al., 1997). Although the 16-,
20-, and 30-kDa bands detected in these cells have not
been described in the previous reports, a similar 16-kDa
protein has been found in studies using in vitro transla-
tion of clones containing the 0.8-kb mRNA (VandeWoude
et al., 1990; Thierer et al., 1992). These studies suggested
that the product was a premature termination product of
translation commonly found in an in vitro translation
ation of BDV. Major unspliced transcripts of BDV are indicated by lines.
n plasmids were transfected into COS-7 cells and analyzed by 15%
s shown at the top of the lanes. Lanes 1, 5, and 9, mock-transfected
, mock-infected C6 cells; lanes 4, 8 and 12, BDV strain He/80-1-infected
1, mock-infected gerbil brain cells; lane 2, BDV strain He/80-1-infectedrganiz
pressio
ntibodie
, and 11system. We found, however, the 16-kDa product in all
BDV-infected cells examined, including infected gerbil
t
t
n
s
t
w
T
t
X
c
s
c
n
a
sent th
t
298 KOBAYASHI ET AL.brain cells (Fig. 1C, lane 2). The 16-kDa band was also
immunoreactive with anti-P monoclonal antibody (MAb)
(Fig. 1B, lanes 6 and 8, and Fig. 1C, lane 2) but not with
anti-X polyclonal antibody (PAb) (Fig. 1B, lanes 10 and
12), indicating that the 16-kDa product is P-specific.
Translation initiates from three different AUG codons
on X/P mRNA
The results shown in Fig. 1 indicated that the X/P
mRNA produces at least three different proteins of 24, 16,
and 14.5 kDa. Therefore, to analyze the nature of the
16-kDa protein, we next generated several mutant forms
of pcX/P. The primers and the detailed contexts of the
mutants are shown in Tables 1, 2, and 4, respectively.
First, to assess the roles of initiation codons of X and P
proteins in production of the 16-kDa protein, COS-7 cells
were transfected with plasmids containing mutations in
AUG49 and/or AUG98 (Fig. 2B). As expected, the plasmids
yielded no 14.5- (X) or 24-kDa (P) products, but expressed
the 16-kDa protein (Fig. 2A, lanes 3 to 5). This result
indicated that the 16-kDa protein was translated from
neither AUG49 nor AUG98 and that it was also unlikely to
T
PCR Primers Used for Plasmid
Primer
1 59-TAAGAATTCGAACA
2 59-TCACTCGAGTTATG
3 59-TCGGAACTCAACAC
4 59-ACTCGATGGTCGCG
5 59-TGGTCTGGGTCTGA
6 59-ATTGAATTCTCCATG
7 59-ATTGAATTCTCCGC
8 59-TATGAATTCGCAAC
9 59-TATGAATTCGCAAG
10 59-TGCGAATTCGCCAC
11 59-AACTCGAGCTACTT
Note. The restriction sites are underlined. The boldface letters repre
TABLE 2
Mutations of Initiation Codons in X/P mRNA
Plasmid
Start codon
X (ATG49) P (ATG98, ATG263)
pcX/P Intact Intact
pcX/PA49T TTG49 Intact
pcX/PA98T Intact TTG98, ATG263
pcX/PA49,98T TTG49 TTG98, ATG263
pcX/PA263T Intact ATG98, TTG263
pcP9 Deletiona Deletiona, ATG263
pcP9AT263GC Deletiona Deletiona, GCG263a The nucleotide sequence from position 1 to 257 was deleted from
he X/Pwt plasmid.be generated by proteolytic cleavage of the P protein. A
band detected in the cells transfected with plasmids
containing the AUG98 mutation seemed to be a product
initiated from a non-AUG codon just after AUG98 on the
ORF of P (Fig. 2A, lanes 4 and 5). Epitope mapping of the
anti-P MAb indicated that the 16-kDa product included
the region from amino acid (aa) residues 41 to 82 of the
P protein (Watanabe et al., 2000b). Therefore, we next
investigated the initiation potential of an AUG263 codon,
located 165 nt downstream from the start codon of the P
protein. We generated two mutant forms, pcX/PA263T and
pcP9, that lack a 257-nt sequence in the 59 region of the
X/P mRNA (Table 2). Transfection analysis of the clones
clearly demonstrated that the 16-kDa product was pro-
duced in pcP9-transfected cells but not in pcX/PA263T-
ransfected cells (Fig. 2A, lanes 6 and 7). Furthermore,
he pcP9AT263GC mutant, in which the initiation codon
AUG263 of the pcP9 plasmid was converted to GCG, did
ot produce the 16-kDa protein (Fig. 2A, lane 8), demon-
trating that the AUG263 codon on the P ORF can initiate
ranslation of the 16-kDa protein, and the 16-kDa protein
as named P9.
he X/P mRNA contains a nonoptimal sequence in
he 59 proximal start codon
The results described above demonstrated that the
/P mRNA includes at least three functional AUG start
odons and that translational initiation at the down-
tream start codons (AUG98 and AUG263) occurs effi-
iently on the mRNA. To analyze the potential mecha-
ism of downstream initiation of X/P mRNA, we gener-
ted mutations in the sequences surrounding AUG49
(Tables 1 and 3), as previous studies of bicistronic viral
mRNAs indicated that nonoptimal sequences of 59 prox-
imal start codons involve efficient initiation of down-
stream AUGs (Kozak, 1991; Fouillot et al., 1993; Chenik et
truction by PCR Mutagenesis
Sequence
ATAAAAAACCAAAT-39
ATGTCCCATTCAT-39
GCGGAGGGTT-39
AATGAGCCTCCTGACTAG-39
AGGAGGGGTTCTTCCTG-39
AGACCCA-39
CAGACCCA-39
ATGAGTTCCGACC-39
ATGGGTTCCGACC-39
CAACGCGACCATCGAG-39
CGTCGTCCTTGTAATCTGGTATGATGTCCCATTC-39
e nucleotides substituted from the BDV X/P mRNA.ABLE 1
Cons
AACCA
GTATG
AGGTT
TTGCC
GATCA
ATCTC
GATCT
CTGTG
CCGCC
CATGG
GTCATal., 1995; Gupta et al., 1996). The mutant containing a
large deletion in the 59-untranslated region (59-UTR)
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299TRANSLATION INITIATION OF BICISTRONIC mRNA OF BDV(pcX/PD38) slightly decreased the expression levels of the
and P9 proteins (Fig. 3, lane 3). In contrast, the levels of
oth proteins were significantly reduced in the cells
ransfected with a mutant with an optimal context of the
UG codon for the initiation of X protein (pcX/PD38K) (Fig.
3, lane 4). Furthermore, the pcX/PK mutant in which the 59
flanking sequences of the AUG49 was converted into the
onsensus Kozak sequence also showed significant de-
reases of both P and P9 proteins (data not shown). The
/X ratios are averages of results obtained from at least
hree independent experiments. This result suggested
hat although the AUG codon for the X protein has a
etter Kozak’s motif (PuNNAUG, prevalence of .90%)
TABLE 3
Context of X ATG49 Start Codon in Mutants
Plasmid 59-UTR X ORF
cX/P Intact Intact
cX/PD38 Deletion 1–38 nt Intact
pcX/PD38K Deletion 1–38 nt CCTGTGATGA49
2
GCCGCCATGGa
FIG. 2. Detection of an internal initiation codon of X/P mRNA of B
transfected with various mutant clones were subjected to Western bl
mock-transfected; 2, pcX/P; 3, pcX/PA49T; 4, pcX/PA98T; 5, pcX/PA49,98T; 6, p
he 59 region of the X/P mRNA. Amino acids (M) for protein initiation a
tart site of the mRNA are also shown.a The boldface letters represent the nucleotide substituted from the
/P mRNA.
t
ahan those for P and P9 (PyNNAUGPu, prevalence ,5%),
he sequence context does not contain a full activity to
revent initiations from the downstream start codons and
leaky scanning mechanism may be involved in initia-
ion of the downstream proteins.
) Mutational analysis of X/P cDNA expression plasmid. COS-7 cells
nalysis with either anti-P MAb (anti-P) or anti-X PAb (anti-X). Lane 1,
63T; 7, pcP9; 8, pcP9AT263GC. (B) Nucleotide and amino acid sequences of
wn in boldface type. The nucleotide positions from the transcriptional
FIG. 3. Mutational analysis of the 59 proximal initiation codon of X/P
mRNA of BDV. COS-7 cells transfected with mutants with deletions or
substitutions in the 59 proximal region were subjected to Western
blotting analysis with anti-BDV rat serum. Lanes 1, mock-transfected; 2,
pcX/P; 3, pcX/PD38; 4, pcX/PD38K. Expression levels of both P and P9
roteins in the cells were determined from the ratio of these proteins toDV. (A
otting a
cX/PA2he X protein. All cited P/X ratios are averages of results obtained from
t least three independent experiments.
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300 KOBAYASHI ET AL.The P9 protein interacts with the other viral proteins
in vivo
Initiation at AUG263 on the P ORF revealed that the P9
rotein lacked the N-terminal 55 aa of the 201-aa P
rotein. This region contains some functional se-
uences, including two possible phosphorylation sites
Ser26 and Ser28) (Schwemmle et al., 1997), one bipartite
uclear localization signal (NLS) (aa 29 to 36) (Shoya et
l., 1998; Schwemmle et al., 1999), and part of the X
rotein-binding site (aa 33 to 115) (Schwemmle et al.,
998). Therefore, we further investigated intracellular lo-
alization and interaction with the other viral compo-
ents in vivo. By transfection of the COS-7 cells with
cP9, the P9 protein was clearly shown to be located in
he nucleus of the transfected cells (Fig. 4A, panel a),
ndicating that an NLS in the C-terminus of the P protein
aa 181 to 193) is sufficient for nuclear import of the
rotein.
Previous studies have demonstrated that the viral N, P,
nd X proteins accumulate in nuclear foci that may also
ontain viral genomic RNA (Schwemmle et al., 1997;
Wehner et al., 1997; Wolff et al., 2000). Therefore, we next
examined whether the P9 protein interacts with the other
viral proteins and accumulates in the BDV-specific nu-
clear foci in BDV-infected cells. To examine this, a plas-
mid that fused to a short FLAG-tag sequence in the
C-terminus of the P9 protein, pcP9-FLAG (Tables 1 and 4),
was expressed in BDV-infected or uninfected human
oligodendroglioma (OL) cells. Although the tagged P9
protein was found to localize only in the nucleus of
uninfected OL cells (Fig. 4A, panel d), a fraction of the P9
protein was also localized in the cytoplasm of BDV-
infected cells in the same distribution as the viral N and
X (Fig. 4A, panels e to h). Furthermore, the tagged P9
protein was found to associate with the BDV-specific foci
in the nucleus of infected cells (Fig. 4A, panels e to h),
demonstrating in vivo interaction of the P9 protein with
the N and X proteins. To confirm in vivo interaction
between the P9 and the other viral proteins, including the
P protein, we performed immunoprecipitation analysis in
uninfected cells and tagged P9 protein expressed in
BDV-infected cells. As shown in Fig. 4B, the P9 protein, as
well as the P protein, was efficiently precipitated with the
N, X, and P proteins (lanes 3, 6, and 9) in the cotrans-
fected cells. Since the P protein expression plasmid,
pP-Wild, is a tagged influenza virus hemagglutinin
epitope in the N-terminus of the P ORF with the original
start codon of the P protein (Shoya et al., 1998), the
plasmid-transfected cells showed an extra small band
that seems to represent the translation product from the
original P initiation site (Fig. 4B, lanes 2 and 5, asterisk).
Moreover, in the P9-FLAG-transfected BDV-infected OL
cells, the tagged P9 protein was coprecipitated with N, X,
and P proteins (Fig. 4C, lanes 2, 4, and 6). These results
indicated that the P9 protein interacts with the other viral
G
aproteins in vivo and suggested that the protein also plays
an important role in viral replication.
DISCUSSION
Viruses use several alternative mechanisms for effi-
cient expression of viral proteins from their small but
complex genomes. One of the most efficient mecha-
nisms is polycistronic coding of viral mRNAs. Such
mRNAs can initiate proteins at start codons that are not
59 proximal and can produce several proteins with dis-
tinct functions (Shaw et al., 1983; Bellini et al., 1985; Ernst
and Shatkin, 1985; Dillon and Gupta, 1989; Senanayake
et al., 1992; Spiropoulou and Nichol, 1993). This mecha-
nism is commonly employed by animal viruses. For ex-
ample, the 1.9-kb Sendai virus (SeV) P/C mRNA encodes
two overlapping ORFs (P and C) and contains four func-
tional AUG codons and one non-AUG codon (Curran and
Kolakofsky, 1988; Curran et al., 1989; Dillon and Gupta,
1989). The influenza B virus RNA segment 6 also con-
tains two ORFs, NA and NB, the start codons of which
are separated by a spacer of only 4 nt (Shaw et al., 1982;
Senanayake et al., 1992). Furthermore, human immuno-
deficiency virus type 1 produces several bicistronic mR-
NAs by RNA splicing to express the viral proteins effi-
ciently (Luciw, 1996). Recent studies have shown that
BDV also produces several bicistronic mRNAs such as
0.8- (X/P), 1.2- (40/38-N), and 2.8-kb (M/G) mRNAs (Briese
et al., 1994; Schneemann et al., 1994; Pyper and Gartner,
1997; Schneider et al., 1997b). These mRNAs are com-
monly found in BDV-infected cells, and proteins initiated
from the downstream start codons of these mRNAs are
efficiently produced in the cells (VandeWoude et al.,
1990; Thierer et al., 1992; Pyper and Gartner, 1997;
Schneider et al., 1997b). These observations indicated
that polycistronic coding of the BDV mRNA is one of the
critical methods for efficient utilization of its compact
genome, in addition to the RNA splicing.
In this paper, we demonstrated that at least three
proteins of 24 (P), 16 (P9), and 14.5 kDa (X) are expressed
in cells transfected with a cDNA clone of the smallest
mRNA of BDV. Of these proteins, the 16-kDa protein, is a
novel form of phosphoprotein of BDV that was detected
in BDV-infected cell lines as well as in infected animal
brain cells. Mutational analysis of the cDNA clone re-
vealed that the 16-kDa protein is initiated at the second
AUG codon, AUG263, on the same ORF of the P protein,
indicating that at least three functional start codons,
AUG49, AUG98, and AUG263, are present in the X/P mRNA
f BDV.
Previous studies of the virus polycistronic mRNAs
ave indicated various mechanisms for translational ini-
iation from downstream start codons (Pelletier and
onenberg, 1988; Kozak, 1991; Futterer et al., 1993;
esteland and Atkins, 1996; Sachs et al., 1997; Latorre et
l., 1998). One possible mechanism is leaky scanning in
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3, and 5, mock-transfected OL/BDV; lanes 2, 4, and 6, pcP9-FLAG-
301TRANSLATION INITIATION OF BICISTRONIC mRNA OF BDVwhich the scanning complex can bypass the first start
codon to some extent when it is not in an optimal context
for initiation. The SeV P/C mRNA uses another mecha-
nism for initiation of the Y1 and Y2 protein, i.e., ribosomal
shunt or discontinuous scanning, in which the scanning
complex assembles at the 59 cap site and scans about
50 nt of the 59-UTR and is then translocated to an ac-
ceptor site close to the Y initiation codons (Latorre et al.,
1998). In BDV, the leaky scanning mechanism has been
reported to be involved in the translational initiation of
the downstream G ORF on the 2.8-kb mRNA (Schneider
et al., 1997b). This previous study revealed that splicing
of the upstream M ORF enhances the translation of G by
converting the M ORF into a 13-aa minicistron that facil-
itates ribosomal reinitiation (Schneider et al., 1997b).
urthermore, primer extension analysis suggested that
here are two mRNA species encoding the 40- and 38-
Da forms of the nucleoprotein of BDV, in which the
olymerase initiates at two different initiation sites sep-
rated by only 12 nt (Pyper and Gartner, 1997). In this
tudy, we demonstrated that mutation of the first AUG
tart codon of the X/P mRNA decreased expression of
he downstream proteins in the ratio of the P and P9
roteins to the X protein (Fig. 3). This suggested that
ranslation from the first start signal of the X/P mRNA is
ot effective, although the signal contains a better
ozak’s motif, and leaky scanning may be involved in the
nitiation of the downstream P and P9 proteins. On the
ther hand, however, it is still possible that the plasmid
equences at the 59 and 39 ends of the plasmid-derived
NA may contribute to some effects on the translation of
/P mRNA in transfected cells. Furthermore, other viral
TABLE 4
Primer Pairs Used for Plasmid Construction by PCR Mutagenesis
Plasmid
Primer pair
Sense Antisense
cX/P Primer 1 Primer 2
cX/PA49T Primer 1 Primers 2 and 3
cX/PA98T Primer 1 Primers 2 and 4
cX/PA49,98T Primer 1 Primers 2 and 3
cX/PA263T Primer 1 Primers 2 and 5
cP9 Primer 6 Primer 2
cP9AT263GC Primer 7 Primer 2
cX/PD38 Primer 8 Primer 2
cX/PD38K Primer 9 Primer 2
cX/P-FLAG Primer 1 Primer 11
cP-FLAG Primer 10 Primer 11
cP9-FLAG Primer 6 Primer 11
transfected OL/BDV. Antibodies used for immunoprecipitation are indi-FIG. 4. Nuclear localization and interactions with the other viral
proteins of BDV P9. (A) Subcellular localization of BDV P9 and of P9 with
N or X protein by indirect immunofluorescence assay in COS-7, OL, or
OL/BDV cells. (a) pcP9-transfected COS-7 cells, anti-P MAb; (b) COS-7
cells, anti-P MAb; (c) mock-transfected OL cells, anti-FLAG MAb; (d)
pcP9-FLAG-transfected OL cells, anti-FLAG MAb; (e and f) pcP9-FLAG-
transfected OL/BDV cells, anti-FLAG MAb (green) and anti-N PAb (red);
(g and h) pcP9-FLAG-transfected OL/BDV cells, anti-FLAG MAb (green)
and anti-X PAb (red); (i) OL/BDV cells, anti-FLAG MAb. (B) Immunopre-
cipitation of P9 protein with the other viral proteins. The COS-7 cells
were cotransfected with P9 plasmid and BDV N, X, or P expression
plasmid, and the interactions were analyzed by immunoprecipitation
assay. Lanes 1 and 4, pP-wild; lane 2, pP-Wild and pcDL-N.Wild; lane 3,
pcP9 and pcDL-N.Wild; lane 5, pP-Wild and pcORFx1-FLAG; lane 6, pcP9
and pcORFx1-FLAG; lane 7, pcP-FLAG; lane 8, pcP-FLAG and pP-Wild;
lane 9, pcP9-FLAG and pP-Wild. Antibodies used for immunoprecipita-
tion are indicated at the top. Detection of the precipitants was analyzed
by anti-P (lanes 1 to 6) or -FLAG (lanes 7 to 9) MAb. (C) Interactioncated at the top. Detection of the precipitants was analyzed by anti-
FLAG (lanes 1 to 4) or -P (lanes 5 and 6) MAb.
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302 KOBAYASHI ET AL.proteins or cellular proteins induced by BDV infection
could affect the translational efficiency of X/P mRNA.
Further studies, for example, introducing a stable stem-
loop structure near the 59 end of the mRNA, are neces-
sary to verify this observation. Experiments are currently
in progress to identify the detailed mechanism of trans-
lation and downstream initiation of the X/P mRNA of BDV.
The translational initiation of the second AUG codon
on the P ORF could produce a novel P9 protein lacking
the N-terminal 55 aa of the P protein. Biological analysis
of the P9 protein demonstrated that the protein could be
translocated into the nucleus and was also found in the
BDV-specific nuclear foci in the infected cells. Further-
more, the protein could interact with the other proteins of
BDV, N, P, and X proteins. These observations strongly
suggested that the P9 protein may play important roles in
irus transcription and/or replication. On the other hand,
hosphorylation of the BDV P protein has been reported
Schwemmle et al., 1997). Interestingly, the P9 protein
acked two possible phosphorylation sites for protein
inase Ce (PKCe) (Ser26 and Ser28) but not the sites for
casein kinase II (CKII) (Ser70 and Ser86). The P protein
as shown to be predominantly and primarily phosphor-
lated by PKCe, the expression pattern of which shows a
distribution similar to that of BDV infection in rat brain
cells, and the second kinase, CKII, might be needed for
the activity of the P protein in the cell nucleus, because
the PKCe phosphorylation sites are located within the
N-terminal NLS of the P protein (Schwemmle et al., 1997).
The absence of phosphorylation sites for the predomi-
nant kinase PKCe in the P9 protein suggested that this
protein might have roles different from those of the BDV
P protein in vivo. Furthermore, we found differential ex-
pression of the P9 protein in BDV-infected animal brain
cells and in BDV-infected cell lines. The expression of
the P9 protein seemed to be more efficient in the infected
cell lines than in infected animal brain cells. This sug-
gested that the infected cell type might regulate transla-
tion of proteins encoded by the mRNA. In fact, we de-
tected several P-specific proteins only in the animal
brain cells, in addition to the P9 protein (Fig. 1C) (Wa-
tanabe et al., 2000a). Further characterization of these
proteins is required to understand the neurotropism and
pathogenesis of BDV.
MATERIALS AND METHODS
BDV-infected cell lines
Mardin–Darby canine kidney (MDCK) and C6 cell lines
persistently infected with BDV (MDCK/BDV and C6BV)
were kindly provided by Dr. R. Rott (Justus-Liebig-Univer-
sita¨t Giessen, Giessen, Germany) and Dr. J. C. de la Torre
(The Scripps Research Institute, La Jolla, CA), respec-
tively. MDCK, MDCK/BDV, C6, C6BV, and COS-7 cells
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum(FBS). OL/BDV cells obtained by establishing a persis-
tent BDV strain HuP2br (Nakamura et al., 2000) infection
in OL cells were grown in high-glucose DMEM supple-
mented with 10% FBS.
Animal samples
BDV-infected Mongolian gerbil brain samples were
obtained 20 days after newborn gerbils were inoculated
intracerebrally with 20 ml of BDV stock [13 104 focus-
orming unit (FFU)/ml] prepared from a homogenized
6BV cell line.
lasmid construction
The BDV cDNA expression plasmid encompassing the
ntire BDV X/P mRNA used for transfection analysis was
enerated as follows. Total RNA extracted from BDV-
nfected MDCK cells was reverse-transcribed as de-
cribed previously (Shoya et al., 1997), and a cDNA
ragment corresponding to X/P mRNA was amplified by
olymerase chain reaction (PCR) with primers 1 and 2
Tables 1 and 4). The amplified fragment was inserted
nto the EcoRI–XhoI site of the pcDNA3 vector (Invitro-
en, San Diego, CA) and named pcX/P. The plasmid was
sed as a DNA template to generate the mutated cDNA
lones. PCR primers used for mutation and the detailed
ontext of the mutants are shown in Tables 1 and 4.
riefly, to generate pcX/PA49T, in which the initiation
codon for the X protein, AUG49, was converted to TTG
(Table 2), PCR was first performed using primers 1 and 3
with pcX/P. The amplified product was then denatured
and used as a PCR sense primer to generate a mutated
fragment with antisense primer 2. The resulting mutated
fragment was converted into the corresponding fragment
of the pcX/P. An essentially similar strategy was used for
construction of the other mutated clones, which contain
a 1-bp substitution in the AUG98 or AUG263 codons of the
P ORF (pcX/PA98T, pcX/PA49,98T, and pcX/PA263T) (Table 2). To
enerate pcP9 and pcP9AT263GC, which lack a 257-nt region
f the 59 sequence of the X/P mRNA (Table 2), PCR was
erformed using primers 6 and 2 and primers 7 and 2,
espectively. An essentially similar strategy was em-
loyed for the mutants of the 59-UTR and X start codon
ontext (pcX/PD38 and pcX/PD38K) (Table 3).
To generate pcX/P-FLAG, pcP-FLAG, and pcP9-FLAG,
which were tagged as the FLAG sequence in the C-
terminus of the P ORF, pcX/P plasmid was amplified by
PCR with antisense primer 11 and sense primers 1, 10,
and 6, respectively (Tables 1 and 4). The amplified frag-
ments were cloned into the EcoRI–XhoI site of the
pcDNA3 vector. Nucleotide sequences of all recombi-
nant constructs were confirmed by DNA sequencing.
The construction of expression plasmids of pcDL-N.Wild
(N), pP-Wild (P), and pcORFx1-FLAG (X) has been de-
scribed elsewhere (Kobayashi et al., 1998; Shoya et al.,
1998; Malik et al., 1999).
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Anti-BDV rat serum was obtained from a 4-week-old
Lewis rat intracranially inoculated with 2 3 102 FFU of
virus stock from C6BV cells (Watanabe et al., 2000a). An
nti-P MAb was prepared by intraperitoneal immuniza-
ion of BALB/c mice with the glutathione column-purified
lutathione S-transferase–BDV P fusion protein. The
ethod of cell fusion was described previously (Ikuta et
l., 1989). The eukaryotic expression plasmid encoding
he full-length BDV P cDNA or a series of deleted forms
f the BDV P cDNA were used for epitope mapping of the
Ab. To determine the reactive region of the MAb in the
roteins, the plasmid was transfected into COS-7 cells
nd analyzed by Western blot analysis (Shoya et al.,
998; Watanabe et al., 2000b). An anti-X rabbit PAb was
indly provided by Dr. Patrick K. Lai (Salem–Teikyo Uni-
ersity, Salem, WV). The anti-N and -P rabbit PAb used
as described previously (Kobayashi et al., 1998).
ukaryotic expression
Cells were seeded at a concentration of 2.5 3 105 cells
per 35-mm-diameter tissue culture dish or per 35-mm-
diameter glass-bottomed culture dish. After overnight
culture at 37°C, the cells were transfected with 2 mg of
lasmid DNAs using TransFast Transfection reagent
Promega, Madison, WI). Two days after transfection, the
ells were subjected to indirect immunofluorescence
nalysis (IFA) or Western blot analysis. To detect the
xpressed proteins, an ECL Western blotting kit (Amer-
ham) was used. The intensity of chemiluminescence of
ach band was quantitated by NIH Image software. All
ited percentages of P/X ratios are averages of results
btained from at least three independent experiments.
rotein pull-down assay
COS-7 was cotransfected with P9 expression plasmid,
cP9, and N, X, or P expression plasmid. BDV-infected
ells, OL/BDV, were transfected with tagged P9 clone,
cP9-FLAG. At 48 h posttransfection, the cells were lysed
y freeze–thaw cycling in a buffer containing 10 mM Tris
pH 7.6), 150 mM NaCl, 0.5% Nonidet-P40, and 1 mM
henylmethylsulfonyl fluoride. After centrifugation, the
oluble fraction was reacted with anti-N, -X, -HA, or
FLAG antibody for 2 h at 4°C, and the precipitates were
hen recovered by incubation with protein A–agarose
eads (Santa Cruz Biotechnology, Inc.) for 24 h at 4°C.
fter thorough washing, proteins bound to the agarose
eads were separated by sodium dodecyl sulfate–poly-
crylamide gel electrophoresis (SDS–PAGE) (12.5% gel)
nd detected by Western blotting with anti-P or -FLAG
Ab.
FAThe transfected cells were fixed with 4% paraformal-
ehyde prior to treatment with 0.4% Triton X-100 (Koba-ashi et al., 1998). The cells were stained with primary
ntibodies [anti-P, -N, -X, and/or -FLAG-specific antibod-
es (1:500 dilutions)]. The cells were washed and stained
ith a fluorescein isothiocynate-conjugated donkey anti-
ouse IgG antibody and/or Cy3-conjugated donkey anti-
abbit IgG and analyzed using a conforcal laser scanning
icroscope (Merdian Instruments Inc.).
ACKNOWLEDGMENTS
This work was partly supported by Special Coordination Funds for
Science and Technology from the Science and Technology Agency
(STA), Japan, and by Grants-in-Aid (A and B) for Scientific Research
from the Ministry of Education, Science, Sports, and Culture, Japan.
REFERENCES
Alkhatib, G., Massie, B., and Briedis, D. J. (1988). Expression of bicis-
tronic measles virus P/C mRNA by using hybrid adenoviruses: Levels
of C protein synthesized in vivo are unaffected by the presence or
absence of the upstream P initiator codon. J. Virol. 62, 4059–4069.
elli, B. A., and Samuel, C. E. (1993). Biosynthesis of reovirus-specified
polypeptides: Identification of regions of the bicistronic reovirus S1
mRNA that affect the efficiency of translation in animal cells. Virology
193, 16–27.
ellini, W. J., Englund, G., Rozenblatt, S., Arnheiter, H., and Richardson,
C. D. (1985). Measles virus P gene codes for two proteins. J. Virol. 53,
908–919.
ode, L., Zimmermann, W., Ferszt, R., Steinbach, F., and Ludwig, H.
(1995). Borna disease virus genome transcribed and expressed in
psychiatric patients. Nat. Med. 1, 232–236.
riese, T., Schneemann, A., Lewis, A. J., Park, Y. S., Kim, S., Ludwig, H.,
and Lipkin, W. I. (1994). Genomic organization of Borna disease virus.
Proc. Natl. Acad. Sci. USA 91, 4362–4366.
henik, M., Chebli, K., and Blondel, D. (1995). Translation initiation at
alternate in-frame AUG codons in the rabies virus phosphoprotein
mRNA is mediated by a ribosomal leaky scanning mechanism. J. Vi-
rol. 69, 707–712.
ubitt, B., and de la Torre, J. C. (1994). Borna disease virus (BDV), a
nonsegmented RNA virus, replicates in the nuclei of infected cells
where infectious BDV ribonucleoproteins are present. J. Virol. 68,
1371–1381.
ubitt, B., Oldstone, C., and de la Torre, J. C. (1994). Sequence and
genome organization of Borna disease virus. J. Virol. 68, 1382–1396.
urran, J., and Kolakofsky, D. (1988). Ribosomal initiation from an ACG
codon in the Sendai virus P/C mRNA. EMBO J. 7, 245–251.
urran, J., and Kolakofsky, D. (1989). Scanning independent ribosomal
initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J.
8, 521–526.
e la Torre, J. C. (1994). Molecular biology of Borna disease virus:
Prototype of a new group of animal viruses. J. Virol. 68, 7669–7675.
illon, P. J., and Gupta, K. C. (1989). Expression of five proteins from the
Sendai virus P/C mRNA in infected cells. J. Virol. 63, 974–977.
rnst, H., and Shatkin, A. J. (1985). Reovirus hemagglutinin mRNA codes
for two polypeptides in overlapping reading frames. Proc. Natl. Acad.
Sci. USA 82, 48–52.
ouillot, N., Tlouzeau, S., Rossignol, J. M., and Jean-Jean, O. (1993).
Translation of the hepatitis B virus P gene by ribosomal scanning as
an alternative to internal initiation. J. Virol. 67, 4886–4895.
utterer, J., Kiss-Laszlo, Z., and Hohn, T. (1993). Nonlinear ribosome
migration on cauliflower mosaic virus 35S RNA. Cell 73, 789–802.
Gesteland, R. F., and Atkins, J. F. (1996). Recoding: Dynamic reprogram-
ming of translation. Annu. Rev. Biochem. 65, 741–768.Gluzman, Y. (1981). SV40-transformed simian cells support the replica-
tion of early SV40 mutants. Cell 23, 175–182.
GK
S
T
304 KOBAYASHI ET AL.Gonzalez-Dunia, D., Cubitt, B., Grasser, F. A., and de la Torre, J. C.
(1997). Characterization of Borna disease virus p56 protein, a surface
glycoprotein involved in virus entry. J. Virol. 71, 3208–3218.
upta, K. C., Ono, E., and Xu, X. (1996). Lack of correlation between
Sendai virus P/C mRNA structure and its utilization of two AUG start
sites from alternate reading frames: Implications for viral bicistronic
mRNAs. Biochemistry 35, 1223–1231.
Haas, B., Becht, H., and Rott, R. (1986). Purification and properties of an
intranuclear virus-specific antigen from tissue infected with Borna
disease virus. J. Gen. Virol. 67, 235–241.
Ikuta, K., Morita, C., Miyake, S., Ito, T., Okabayashi, M., Sano, K., Nakai,
M., Hirai, K., and Kato, S. (1989). Expression of human immunodefi-
ciency virus type 1 (HIV-1) gag antigens on the surface of a cell line
persistently infected with HIV-1 that highly expresses HIV-1 antigens.
Virology 170, 408–417.
Iwata, Y., Takahashi, K., Peng, X., Fukuda, K., Ohno, K., Ogawa, T.,
Gonda, K., Mori, N., Niwa, S., and Shigeta, S. (1998). Detection and
sequence analysis of Borna disease virus p24 RNA from peripheral
blood mononuclear cells of patients with mood disorders or schizo-
phrenia and of blood donors. J. Virol. 72, 10044–10049.
Kishi, M., Nakaya, T., Nakamura, Y., Zhong, Q., Ikeda, K., Senjo, M.,
Kakinuma, M., Kato, S., and Ikuta, K. (1995). Demonstration of human
Borna disease virus RNA in human peripheral blood mononuclear
cells. FEBS. Lett. 364, 293–297.
Kliche, S., Briese, T., Henschen, A. H., Stitz, L., and Lipkin, W. I. (1994).
Characterization of a Borna disease virus glycoprotein, gp18. J. Virol.
68, 6918–6923.
Kliche, S., Stitz, L., Mangalam, H., Shi, L., Binz, T., Niemann, H., Briese,
T., and Lipkin, W. I. (1996). Characterization of the Borna disease virus
phosphoprotein, p23. J. Virol. 70, 8133–8137.
obayashi, T., Shoya, Y., Koda, T., Takashima, I., Lai, P. K., Ikuta, K.,
Kakinuma, M., and Kishi, M. (1998). Nuclear targeting activity asso-
ciated with the amino-terminal region of the Borna disease virus
nucleoprotein. Virology 243, 188–197.
Kozak, M. (1991). Structural features in eukaryotic mRNAs that modu-
late the initiation of translation. J. Biol. Chem. 266, 19867–19870.
Latorre, P., Kolakofsky, D., and Curran, J. (1998). Sendai virus Y proteins
are initiated by a ribosomal shunt. Mol. Cell. Biol. 18, 5021–5031.
Lipkin, W. I., Travis, G. H., Carbone, K. M., and Wilson, M. C. (1990).
Isolation and characterization of Borna disease agent cDNA clones.
Proc. Natl. Acad. Sci. USA 87, 4184–4188.
Luciw, P. A. (1996). Human immunodeficiency virus and their replica-
tion. In “Virology” (B. N. Fields, D. M. Knipe, et al., Eds.), 3rd ed., pp.
1881–1952. Raven Press, New York.
Ludwig, H., Bode, L., and Gosztonyi, G. (1988). Borna disease: A per-
sistent virus infection of the central nervous system. Prog. Med. Virol.
35, 107–151.
Malik, T. H., Kobayashi, T., Ghosh, M., Kishi, M., and Lai, P. K. (1999).
Nuclear localization of the protein from the open reading frame x1 of
the Borna disease virus was through interactions with the viral
nucleoprotein. Virology 258, 65–72.
McClure, M. A., Thibault, K. J., Hatalski, C. G., and Lipkin, W. I. (1992).
Sequence similarity between Borna disease virus p40 and a dupli-
cated domain within the paramyxovirus and rhabdovirus polymerase
proteins. J. Virol. 66, 6572–6577.
Nakamura, Y., Takahashi, H., Shoya, Y., Nakaya, T., Watanabe, M.,
Tomonaga, K., Iwahashi, K., Ameno, K., Momiyama, N., Taniyama, H.,
Sato, T., Kurata, T., de la Torre, J. C., and Ikuta, K. (2000). Isolation of
Borna disease virus from human brain tissue. J. Virol. 74, 4601–4611.
Pelletier, J., and Sonenberg, N. (1988). Internal initiation of translation of
eukaryotic mRNA directed by a sequence derived from poliovirus
RNA. Nature 334, 320–325.
Pyper, J. M., and Gartner, A. E. (1997). Molecular basis for the differen-
tial subcellular localization of the 38- and 39-kilodalton structural
proteins of Borna disease virus. J. Virol. 71, 5133–5139.Pyper, J. M., Richt, J. A., Brown, L., Rott, R., Narayan, O., and Clements,
J. E. (1993). Genomic organization of the structural proteins of Borna Tdisease virus revealed by a cDNA clone encoding the 38-kDa pro-
tein. Virology 195, 229–238.
Rott, R., Herzog, S., Fleischer, B., Winokur, A., Amsterdam, J., Dyson, W.,
and Koprowski, H. (1985). Detection of serum antibodies to Borna
disease virus in patients with psychiatric disorders. Science 228,
755–756.
Sachs, A. B., Sarnow, P., and Hentze, M. W. (1997). Starting at the
beginning, middle, and end: Translation initiation in eukaryotes. Cell
89, 831–838.
Schadler, R., Diringer, H., and Ludwig, H. (1985). Isolation and charac-
terization of a 14500 molecular weight protein from brains and tissue
cultures persistently infected with Borna disease virus. J. Gen. Virol.
66, 2479–2484.
Schneemann, A., Schneider, P. A., Kim, S., and Lipkin, W. I. (1994).
Identification of signal sequences that control transcription of Borna
disease virus, a nonsegmented, negative-strand RNA virus. J. Virol.
68, 6514–6522.
Schneemann, A., Schneider, P. A., Lamb, R. A., and Lipkin, W. I. (1995).
The remarkable coding strategy of Borna disease virus: A new
member of the nonsegmented negative strand RNA viruses. Virology
210, 1–8.
Schneider, P. A., Hatalski, C. G., Lewis, A. J., and Lipkin, W. I. (1997a).
Biochemical and functional analysis of the Borna disease virus G
protein. J. Virol. 71, 331–336.
Schneider, P. A., Kim, R., and Lipkin, W. I. (1997b). Evidence for trans-
lation of the Borna disease virus G protein by leaky ribosomal
scanning and ribosomal reinitiation. J. Virol. 71, 5614–5619.
Schneider, P. A., Schneemann, A., and Lipkin, W. I. (1994). RNA splicing
in Borna disease virus, a nonsegmented, negative-strand RNA virus.
J. Virol. 68, 5007–5012.
Schwemmle, M., De, B., Shi, L., Banerjee, A., and Lipkin, W. I. (1997).
Borna disease virus P-protein is phosphorylated by protein kinase Ce
and casein kinase II. J. Biol. Chem. 272, 21818–21823.
Schwemmle, M., Jehle, C., Shoemaker, T., and Lipkin, W. I. (1999).
Characterization of the major nuclear localization signal of the Borna
disease virus phosphoprotein. J. Gen. Virol. 80, 97–100.
Schwemmle, M., Salvatore, M., Shi, L., Richt, J., Lee, C. H., and Lipkin,
W. I. (1998). Interactions of the Borna disease virus P, N, and X
proteins and their functional implications. J. Biol. Chem. 273, 9007–
9012.
Senanayake, S. D., Hofmann, M. A., Maki, J. L., and Brian, D. A. (1992).
The nucleocapsid protein gene of bovine coronavirus is bicistronic.
J. Virol. 66, 5277–5283.
Shaw, M. W., Choppin, P. W., and Lamb, R. A. (1983). A previously
unrecognized influenza B virus glycoprotein from a bicistronic mRNA
that also encodes the viral neuraminidase. Proc. Natl. Acad. Sci. USA
80, 4879–4883.
Shaw, M. W., Lamb, R. A., Erickson, B. W., Briedis, D. J., and Choppin,
P. W. (1982). Complete nucleotide sequence of the neuraminidase
gene of influenza B virus. Proc. Natl. Acad. Sci. USA 79, 6817–6821.
Shoya, Y., Kobayashi, T., Koda, T., Ikuta, K., Kakinuma, M., and Kishi, M.
(1998). Two proline-rich nuclear localization signals in the amino-
and carboxyl-terminal regions of the Borna disease virus phospho-
protein. J. Virol. 72, 9755–9762.
Shoya, Y., Kobayashi, T., Koda, T., Lai, P. K., Tanaka, H., Koyama, T., Ikuta,
K., Kakinuma, M., and Kishi, M. (1997). Amplification of a full-length
Borna disease virus (BDV) cDNA from total RNA of cells persistently
infected with BDV. Microbiol. Immunol. 41, 481–486.
Spiropoulou, C. F., and Nichol, S. T. (1993). A small highly basic protein
is encoded in overlapping frame within the P gene of vesicular
stomatitis virus. J. Virol. 67, 3103–3110.
titz, L., Bilzer, T., Richt, J. A., and Rott, R. (1993). Pathogenesis of Borna
disease. Arch. Virol. 7(Suppl.), 135–151.
hiedemann, N., Presek, P., Rott, R., and Stitz, L. (1992). Antigenic
relationship and further characterization of two major Borna disease
virus-specific proteins. J. Gen. Virol. 73, 1057–1064.
hierer, J., Riehle, H., Grebenstein, O., Binz, T., Herzog, S., Thiedemann,
305TRANSLATION INITIATION OF BICISTRONIC mRNA OF BDVN., Stitz, L., Rott, R., Lottspeich, F., and Niemann, H. (1992). The 24K
protein of Borna disease virus. J. Gen. Virol. 73, 413–416.
VandeWoude, S., Richt, J. A., Zink, M. C., Rott, R., Narayan, O., and
Clements, J. E. (1990). A Borna virus cDNA encoding a protein
recognized by antibodies in humans with behavioral diseases. Sci-
ence 250, 1278–1281.
Walker, M. P., Jordan, I., Briese, T., Fischer, N., and Lipkin, W. I. (2000).
Expression and characterization of the Borna disease virus polymer-
ase. J. Virol. 74, 4425–4428.
Watanabe, M., Kobayashi, T., Tomonaga, K., and Ikuta, K. (2000a).
Antibodies to Borna disease virus in infected adult rats: An early
appearance of anti-p10 antibody and recognition of novel virus-
specific proteins in infected animal brain cells. J. Vet. Med. Sci. 62,
775–778.
Watanabe, M., Zhong, Q., Kobayashi, T., Kamitani, W., Tomonaga, K., andIkuta, K. (2000b). Molecular ratio between Borna disease viral-p40
and -p24 proteins in infected cells determined by quantitative anti-
gen capture ELISA. Microbiol. Immunol. 44, 765–772.
Wehner, T., Ruppert, A., Herden, C., Frese, K., Becht, H., and Richt,
J. A. (1997). Detection of a novel Borna disease virus-encoded 10
kDa protein in infected cells and tissues. J. Gen. Virol. 78, 2459–
2466.
Williams, M. A., and Lamb, R. A. (1989). Effect of mutations and dele-
tions in a bicistronic mRNA on the synthesis of influenza B virus NB
and NA glycoproteins. J. Virol. 63, 28–35.
Wolff, T., Pfleger, R., Wehner, T., Reinhardt, J., and Richt, J. A. (2000). A
short leucine-rich sequence in the Borna disease virus p10 protein
mediates association with the viral phospho- and nucleoproteins.
J. Gen. Virol. 81, 939–947.
